PharVision Advisers’s Flowers Foods FLO Stock Holding History

PharVision Advisers’s Portfolio FLO Stock Details FLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-13,766	Closed	-$262K	–	328
2025 Q1	$262K	Buy	+13,766	New	+$263K	0.36%	129

Other funds holding FLO

Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

PharVision Advisers's FLO Position: Q2 2025 in Review

PharVision Advisers sold out of Flowers Foods (FLO) in Q2 2025, closing a stake of 13,766 shares — an estimated $262K sold.

PharVision Advisers first reported a position in FLO in Q1 2025 and held it in 1 quarter. The position peaked at $262K in Q1 2025. 420 funds tracked by Wall St. Rank hold FLO as of Q2 2025.

PharVision Advisers reported no remaining Flowers Foods position as of Q2 2025 after selling out during the quarter.
PharVision Advisers sold 13,766 Flowers Foods shares in Q2 2025, an estimated $262K.
PharVision Advisers first reported a position in Flowers Foods in Q1 2025 and held it in 1 quarter.
PharVision Advisers's Flowers Foods position peaked at $262K in Q1 2025.
420 funds tracked by Wall St. Rank held Flowers Foods as of Q2 2025.

Based on PharVision Advisers's 13F filing for Q2 2025, filed 13 Aug 2025.